Effects of multiple doses of Albiglutide on the pharmacokinetics, Pharmacodynamics, and safety of Digoxin, Warfarin, or a low-dose oral contraceptive
Contact your healthcare provider or poison control immediately, do not take your next scheduled dose, and seek emergency care if you experience persistent vomiting, severe abdominal pain, or signs of dehydration
Both medications should be used alongside a comprehensive weight management programme including dietary changes, increased physical activity, and behavioural support
Additionally, compounding can be conducted in outsourcing facilities under the direct supervision of a licensed pharmacist
Retatrutide (LY3437943), marketed here as Reta-Solution, is an investigational multi-receptor peptide agonist that targets the receptors for GIP, GLP-1 and glucagon, and is used in experimental models of obesity, glycemic control and metabolic regulation